Monoclonal antibodies can help high-risk people with COVID-19. But getting the drug to patients remains a challenge.



[ad_1]

After Kathy Lefczik, a 62-year-old woman from Maple Shade, tested positive on January 15, her doctor Virtua suggested she undergo monoclonal antibody therapy. She suffers from diabetes and hypertension, risk factors that made her eligible for the drug. She had eaten with a friend – inside without a mask – the previous Saturday. The next day the friend, who is older and has chronic lung problems, showed symptoms. The next day Lefczik had a headache, cough, runny nose, fatigue and muscle pain. “Because of my underlying issues, I was very scared,” she says.



[ad_2]
Source link